respiratori
viral
infect
frequent
clinic
syndrom
affect
children
adult
earli
detect
fundament
avoid
infectionrel
risk
reduc
healthcar
cost
incur
unnecessari
antibiot
treatment
studi
perform
characterist
two
commerci
method
panther
assay
holog
inc
san
diego
ca
usa
compar
respiratori
panel
seegen
seoul
south
korea
detect
influenza
flu
influenza
b
flu
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
human
metapneumoviru
hmpv
rhinoviru
rv
adenoviru
adv
target
total
specimen
collect
prospect
retrospect
includ
discord
result
examin
use
anoth
commerci
product
respiratori
kit
rieux
marci
letoil
franc
high
agreement
method
concord
kappa
k
valu
ci
specif
analysi
method
viral
agent
demonstr
compar
sensit
specif
rang
good
predict
valu
prospect
part
studi
good
agreement
method
also
found
valu
obtain
rang
lowest
hmpv
k
ci
rv
k
ci
amplif
effici
measur
accord
valu
cycl
threshold
c
obtain
amplif
test
significantli
better
panther
fusion
flu
flu
b
hmpv
rv
regard
discord
result
rgene
show
higher
agreement
panther
fusionposit
specimen
neg
allplex
n
allplexposit
sampl
neg
panther
fusion
n
summari
panther
fusion
prove
effici
fullyautom
methodolog
requir
shorter
handson
turnaround
time
allplex
posit
n
neg
n
total
n
flu
b
posit
n
neg
n
total
n
rsv
posit
n
neg
n
total
n
adv
posit
n
neg
n
total
n
hmpv
posit
n
neg
n
total
n
rv
posit
n
neg
n
total
n
piv
posit
n
neg
n
median
valu
calcul
use
gener
amplif
valu
influenza
viru
flu
viru
influenza
flu
b
viru
influenza
b
rsv
respiratori
syncyti
viru
adv
adenoviru
hmpv
human
metapneumoviru
rv
rhinoviru
iqr
interquartil
rang
http
doi
virus
common
etiolog
agent
respiratori
infect
caus
comorbid
mortal
children
adult
consequ
earli
detect
respiratori
virus
fundament
reduc
risk
associ
infect
nosocomi
transmiss
avoid
inappropri
treatment
timeconsum
laboratori
test
implement
nucleic
acid
amplif
test
naat
revolution
diagnosi
viral
respiratori
tract
infect
due
high
sensit
specif
rapid
viru
identif
possibl
detect
pathogen
could
identifi
convent
diagnost
method
howev
mani
commerci
avail
test
focus
detect
influenza
respiratori
syncyti
viru
rsv
use
pointofcar
facil
limit
number
sampl
analyz
simultan
therefor
need
rapid
fulli
autom
commerci
techniqu
allow
detect
broad
panel
respiratori
virus
adapt
variabl
sampl
size
would
enabl
applic
diagnost
algorithm
consid
paramet
patient
characterist
immunosuppress
basal
respiratori
diseas
season
virus
among
commerci
system
current
avail
seegen
seoul
south
korea
offer
simultan
detect
viral
target
includ
respiratori
viru
medic
import
also
provid
epidemiolog
inform
detect
influenza
subtyp
rsv
parainfluenza
viru
type
well
identif
coronavirus
produc
respiratori
infect
human
assay
allow
differenti
detect
enteroviru
picornaviru
singular
featur
among
commerci
platform
perform
syndrom
diagnosi
viral
respiratori
infect
characterist
made
routin
method
implement
laboratori
start
flu
season
allplex
appli
technolog
multipl
detect
temperatur
mudt
allow
simultan
amplif
multipl
target
wavelength
without
melt
curv
analysi
panther
platform
holog
inc
san
diego
ca
usa
recent
releas
market
present
sampletoresult
autom
one
main
characterist
although
detect
smaller
number
viral
target
reduc
respons
time
random
access
possibl
test
sampl
urgent
suffici
attract
argument
consid
clinic
use
purpos
studi
compar
two
commerci
product
panther
fusion
assay
allplex
respiratori
panel
detect
influenza
flu
influenza
b
flu
b
rsv
parainfluenza
viru
piv
human
metapneumoviru
hmpv
rhinoviru
rv
adenoviru
adv
use
singl
patient
sampl
assay
consist
three
multiplex
realtim
pcr
rrtpcr
panel
recent
shown
good
perform
detect
batteri
respiratori
virus
date
compar
naat
perform
manner
blind
result
naat
panther
fusion
three
differ
multiplex
rrtpcr
vitro
diagnost
test
use
detect
differenti
respiratori
virus
fusion
flu
abrsv
detect
flu
flu
b
rsv
fusion
paraflu
detect
fusion
adv
hmpvrv
detect
adv
hmpv
rv
supernat
assay
volum
transfer
specimen
lysi
tube
load
directli
onto
panther
fusion
system
platform
perform
autom
nucleic
acid
extract
amplif
gene
target
sequenc
rrtpcr
allplex
compos
three
differ
panel
multiplex
onestep
rrtpcr
assay
panel
detect
flu
flu
b
rsv
rsv
b
flu
subtyp
panel
detect
adv
hmpv
human
enteroviru
hev
panel
rv
human
coronaviru
hcov
human
bocaviru
hbov
nucleic
acid
extract
supernat
assay
volum
perform
microlab
nimbu
ivd
retrospect
sampl
microlabstarlet
ivd
prospect
sampl
use
starmag
x
univers
cartridg
kit
seegen
seoul
south
korea
rrtpcr
system
biorad
laboratori
hercul
ca
usa
use
analysi
result
done
use
seegen
viewer
softwar
main
characterist
two
test
compar
studi
respect
degre
autom
test
turnaround
time
characterist
amplif
sampl
volum
possibl
primari
tube
util
stat
capabl
reagent
storag
condit
shown
tabl
platform
allow
visual
amplif
curv
c
valu
interpret
result
carri
case
follow
manufactur
instruct
instrument
use
assay
provid
compani
use
standard
version
commerci
avail
third
pcrbase
assay
marci
letoil
franc
use
duplex
reaction
carri
refer
method
case
discord
result
follow
rgene
panel
use
influenza
ab
rsvhmpv
rhino
evcc
adv
hbov
hcovhpiv
nucleic
acid
extract
supernat
assay
elut
volum
perform
use
nuclisen
easymag
marci
letoil
franc
rrtpcr
use
lightcycl
system
instrument
ii
roch
life
scienc
indianapoli
usa
studi
divid
two
part
conduct
hospit
universitario
de
octubr
madrid
spain
prospect
part
conduct
decemb
flu
season
sampl
patient
suspect
respiratori
viral
infect
test
simultan
assay
retrospect
part
studi
carri
test
sampl
virus
usual
circul
month
decemb
januari
also
includ
viral
strain
differ
year
purpos
store
sampl
select
differ
respiratori
virus
detect
one
diagnost
method
use
time
laboratori
includ
rrtpcr
assay
andor
shellvial
cultur
one
viru
previous
detect
posit
sampl
addit
retrospect
studi
includ
sampl
presenc
common
respiratori
virus
rule
rrtpcr
sampl
includ
studi
belong
total
patient
total
clinic
specimen
analyz
nasopharyng
exud
nasopharyng
aspir
pediatr
patient
bal
advposit
cultur
supernat
nasopharyng
sampl
collect
flock
swab
viral
transport
medium
copan
diagnost
brescia
itali
analysi
sampl
vortex
swab
remov
transport
devic
nasopharyng
aspir
bal
fluid
specimen
dilut
utm
viral
transport
medium
upon
arriv
laboratori
specimen
centrifug
xg
min
supernat
use
test
retrospect
studi
order
avoid
multipl
freezingthaw
sampl
residu
supernat
retriev
storag
divid
three
aliquot
refrozen
first
two
aliquot
specimen
thaw
test
instrument
third
kept
use
case
discrep
sampl
consid
true
posit
tp
viral
target
detect
sampl
two
assay
true
neg
tn
two
assay
detect
viral
target
accord
criteria
test
result
individu
assay
categor
fals
posit
fp
fals
neg
fn
posit
neg
result
correspond
tn
tp
sampl
respect
primari
diagnost
assay
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
calcul
correspond
twosid
score
wilson
confid
interv
ci
also
estim
interrat
agreement
statist
kappa
valu
k
use
compar
detect
viral
target
panther
fusion
allplex
assay
median
iqr
c
valu
compar
assay
calcul
seven
analyz
virus
twotail
student
test
perform
determin
statist
signific
pvalu
consid
statist
signific
calcul
perform
vassarstat
statist
comput
web
site
http
vassarstatsnet
studi
approv
ethic
committe
hospit
universitario
de
octubr
ec
number
ceic
number
posit
sampl
viral
agent
investig
shown
tabl
sampl
one
pathogen
detect
identif
flu
subtyp
rsv
piv
type
base
result
obtain
allplex
piv
result
confirm
panther
fusion
assay
tp
tn
fp
fn
result
obtain
test
virus
shown
tabl
global
test
show
excel
sensit
specif
valu
panther
fusion
sensit
valu
viral
target
wherea
allplex
show
valu
lower
detect
hmpv
rv
though
still
sampl
discrep
two
assay
allplex
detect
rv
posit
detect
panther
fusion
one
confirm
rgene
hand
panther
fusion
detect
hmpv
sampl
posit
allplex
confirm
rgene
regard
neg
control
sampl
respiratori
virus
previous
identifi
allplex
detect
viral
agent
panther
fusion
fals
posit
result
detect
adv
confirm
rgene
six
invalid
sampl
detect
allplex
panel
one
sampl
allplex
panel
n
total
five
sampl
invalid
panther
fusion
advhmpvrv
andor
paraflu
panel
n
discard
sampl
invalid
result
total
sampl
analyz
flu
b
rsv
adv
hmpv
rv
sampl
piv
sampl
viru
detect
overal
result
obtain
primari
assay
viru
shown
tabl
two
primari
assay
show
neg
result
virus
investig
sampl
discrep
result
sampl
regard
sensit
specif
methodolog
yield
high
valu
rang
good
predict
valu
although
gener
panther
fusion
tend
sensit
compar
viral
target
allplex
assay
allow
differenti
result
base
subtyp
sampl
posit
flu
nt
subtyp
rsv
rsv
rsv
b
sampl
allplex
detect
virus
includ
diagnost
capabl
panther
fusion
hcov
n
hcov
n
hev
n
hbov
n
specif
comparison
method
seven
virus
perform
analyz
result
obtain
prospect
retrospect
part
studi
overal
agreement
rang
lowest
k
valu
determin
hmpv
k
ci
rv
k
ci
tabl
method
requir
number
amplif
cycl
amplif
effici
evalu
compar
median
c
valu
assay
tabl
comparison
result
obtain
amplif
flu
case
allplex
c
obtain
gener
amplif
viru
use
four
seven
virus
final
discord
result
interpret
consid
result
first
two
assay
along
rgene
assay
tabl
discord
result
virus
analyz
found
frequent
rv
n
sampl
flu
n
hmpv
n
test
regard
flu
viru
discord
allplex
assay
associ
subtyp
detect
nontyp
strain
c
valu
obtain
assay
analyz
sampl
discord
result
fig
overal
refer
method
show
higher
agreement
panther
fusionposit
specimen
neg
allplex
n
allplexposit
sampl
neg
panther
fusion
n
although
differ
statist
signific
flu
p
respiratori
viral
infect
major
global
health
problem
today
requir
accur
diagnost
tool
must
thoroughli
evalu
prior
implement
routin
laboratori
practic
studi
compar
perform
panther
fusion
assay
allplex
respiratori
panel
approv
vitro
diagnost
ceivd
use
rgene
technolog
refer
method
result
demonstr
technolog
produc
compar
result
detect
seven
virus
respons
major
viral
respiratori
infect
panther
fusion
respiratori
assay
show
slightli
better
sensit
allplex
panel
furthermor
panther
fusion
show
better
amplif
effici
flu
b
hmpv
rv
detect
may
explain
differ
detect
technolog
use
differ
target
gene
although
overal
agreement
method
high
lower
valu
observ
rv
hmpv
two
virus
great
genom
divers
noteworthi
discord
result
detect
method
tabl
discord
result
allplex
panther
fusion
result
obtain
refer
method
rgene
associ
high
c
valu
suggest
low
viral
genom
load
clinic
sampl
close
limit
detect
assay
sever
multiplex
respiratori
assay
ceivd
approv
current
avail
market
among
allplex
respiratori
assay
shown
good
perform
reliabl
result
recentlydevelop
panther
fusion
system
fulli
autom
randomaccess
test
system
shown
compar
result
obtain
esensor
rvp
esensor
genmark
dx
carlsbad
ca
lyra
quidel
san
diego
ca
respiratori
assay
result
show
also
true
compar
allplex
technolog
method
detect
broader
varieti
virus
singl
channel
requir
handson
time
consequ
slower
turnaround
time
panther
fusion
assay
show
greater
agreement
third
refer
rrtpcr
method
allplex
panel
indic
slightli
better
specif
target
virus
studi
everi
type
clinic
respiratori
sampl
nasopharyng
aspir
nasopharyng
exud
bal
analyz
result
signific
number
sampl
multipl
virus
codetect
assay
furthermor
methodolog
use
retrospect
studi
ensur
test
carri
includ
refer
test
sampl
treat
condit
avoid
possibl
interfer
caus
repeat
freezethaw
sampl
conclus
panther
fusion
valid
alongsid
allplex
sensit
specif
assay
detect
common
virus
respons
respiratori
infect
allow
fulli
autom
rrtpcr
process
random
access
clinic
appropri
turnaround
time
thu
suitabl
method
implement
routin
clinic
viral
diagnost
